Vemurafenib Recruiting Phase 2 Trials for Thyroid Cancers Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01709292Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer